Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria

INTRODUCTION: Malaria is the most relevant parasitic disease worldwide, and still accounts for 1 million deaths each year. Since current antimalarial drugs are unable to prevent death in severe cases, new therapeutic strategies have been developed. Mesenchymal stromal cells (MSC) confer host resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Mariana C, Silva, Johnatas D, Pádua, Tatiana A, Torres, Natália D, Antunes, Mariana A, Xisto, Debora G, Abreu, Thiago P, Capelozzi, Vera L, Morales, Marcelo M, Sá Pinheiro, Ana A., Caruso-Neves, Celso, Henriques, Maria G, Rocco, Patricia RM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462088/
https://www.ncbi.nlm.nih.gov/pubmed/25998168
http://dx.doi.org/10.1186/s13287-015-0093-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462088/
https://www.ncbi.nlm.nih.gov/pubmed/25998168
http://dx.doi.org/10.1186/s13287-015-0093-2

Ejemplares similares